SLC5A2 and Hyperglycemia: A recent study in a lean mouse model of hyperglycemia demonstrated that, although SGLT2 inhibitors led to an apparent improvement in exercise capacity due to fat loss in sedentary mice, true improvements in aerobic capacity were only observed in those undergoing exercise training, even after adjusting for lean body mass.48